Skip to main content
. 2025 Apr 22;26(9):3933. doi: 10.3390/ijms26093933
HB Hepatoblastoma
LXR Liver X Receptor
RXR Retinoid X Receptor
TRIM29 Tripartite motif containing 29
CTNNB1 CATENIN β1
IPA Ingenuity Pathway Analysis
FXR Farnesoid X Receptor
LBD Ligand binding domain
ATDC Ataxia-telangiectasia group D-associated protein
Dvl2 Disheveled 2
GSK3β Glycogen synthase kinase 3β
MMP-9 Matrix metalloproteinase 9
LD50 Lethal dose 50%
Rb Retinoblastoma
HCC Hepatocellular carcinoma
CSC Cancer stem cell
DMEM Dulbecco’s modified Eagle’s medium
FBS Fetal bovine serum
PBS Phosphate-buffered saline
RIPA Radio-immunoprecipitation assay
mTOR Mammalian target of rapamycin
NP40 Nonidet P-40
DMSO Dimethyl sulfoxide